MS | pharmaphorum

Skip to main content

Monday 10 August 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

MS

Views & Analysis

digital-link-dmd

Case study: Ensuring safety by digitally linking prescriptio...

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

Views & Analysis

SalfordTeam

‘Listen to your patients’: the best MS care honoured at QuDo...

Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.

Views & Analysis

Social network - vector illustration.

5 questions: making Multiple Sclerosis care more patient-cen...

Trishna Bharadia, Multiple Sclerosis patient advocate, wants to make MS care more patient-centric.

Views & Analysis

The young woman support the elderly woman

Addressing the growing need for better Multiple Sclerosis ca...

Jo Sopala of the MS Trust describes the organisation's work in creating better multiple sclerosis care.

Views & Analysis

Illustration of a nerve cell on a colored background with light effects

Multiple sclerosis: A patient’s perspective

A patient's view of the challenges facing people with multiple sclerosis.

News

Roche Rituxan approval

FDA delays decision on key Roche MS drug

FDA to review new manufacturing data.

Load more results

Editor's Picks

Curium strikes $8bn deal to buy radiopharma rival Lantheus

Pathos AI signs two cancer deals with Alphamab and AZ

FDA clears Moderna's mRNA-based seasonal flu shot

Sources quash rumours of an AZ/BMS mega-merger

Novo Nordisk wins Netherlands GLP-1 compounding lawsuit

News

Ex-BioNTech execs launch 'AI-native' cancer company

Ex-BioNTech execs launch 'AI-native' cancer company

Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company